HRP20220378T1 - Kompozicija koja oblikuje lipidni sloj za primjenu na površinu živog organizma - Google Patents

Kompozicija koja oblikuje lipidni sloj za primjenu na površinu živog organizma Download PDF

Info

Publication number
HRP20220378T1
HRP20220378T1 HRP20220378TT HRP20220378T HRP20220378T1 HR P20220378 T1 HRP20220378 T1 HR P20220378T1 HR P20220378T T HRP20220378T T HR P20220378TT HR P20220378 T HRP20220378 T HR P20220378T HR P20220378 T1 HRP20220378 T1 HR P20220378T1
Authority
HR
Croatia
Prior art keywords
agent
composition according
weight
silicone oil
lipid layer
Prior art date
Application number
HRP20220378TT
Other languages
English (en)
Inventor
Jan HOLMBÄCK
Anders Carlsson
Original Assignee
Lipidor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipidor Ab filed Critical Lipidor Ab
Publication of HRP20220378T1 publication Critical patent/HRP20220378T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)

Claims (10)

1. Kompozicija nosača za topikalnu primjenu koja oblikuje lipidni sloj na koži ili membrani sluznice i sadrži isparljivo silikonsko ulje, od 10 težinskih % do 30 težinskih % fosfolipida, od 10 težinskih % do 30 težinskih % etanola, izborno vodu u količini od 5 težinskih % ili manje, pri čemu je silikonsko ulje sa točkom ključanja iznad 180°C, posebno iznad 200°C, i pri čemu je silikonsko ulje sa toplinom vaporizacije (kJ/kg) na 25°C od oko 100 kJ/kg do oko 300 kJ/kg, pod uvjetom da sadržaj isparljivog silikonskog ulja iznosi 50 težinskih % ili više.
2. Kompozicija prema patentnom zahtjevu 1, gdje je silikonsko ulje sa toplinom vaporizacije (kJ/kg) na 25 °C od 120 kJ/kg do 200 kJ/kg, posebno od 140 kJ/kg do 180 kJ/kg.
3. Kompozicija prema patentnom zahtjevu 1 ili 2, gdje isparljivo silikonsko ulje sadrži jedan od dekametilciklopentasiloksana i dodekametilcikloheksasiloksana.
4. Kompozicija prema patentnom zahtjevu 1 ili 2, gdje isparljivo silikonsko ulje sadrži jedan od heptasiloksana i oktasiloksana.
5. Kompozicija prema bilo kojem od patentnih zahtjeva od 1 do 4, koja sadrži manje od 1 težinskih % vode.
6. Farmaceutska ili kozmetička kompozicija koja oblikuje lipidni sloj i sadrži kompoziciju nosača prema bilo kojem od patentnih zahtjeva od 1 do 5 i farmakološki ili kozmetički aktivno sredstvo ili protektivno sredstvo.
7. Kompozicija prema patentnom zahtjevu 6, gdje je sredstvo farmakološki aktivno sredstvo izabrano iz grupe koju čine: antimikrobno sredstvo, antibiotik; antimikotik; antibakterijsko sredstvo; sredstvo protiv gljivica; antivirusno sredstvo; antiseptik; anti-flogistik; sredstvo protiv svraba; sredstvo protiv psorijaze; sredstvo protiv kašlja; sredstvo protiv alopecije; sredstvo protiv akni; protuupalno sredstvo; sredstvo protiv čira; lokalni anestetik.
8. Kompozicija prema patentnom zahtjevu 6, gdje je sredstvo kozmetički aktivno sredstvo izabrano iz grupe koju čine: antiperspirant; antisudoralno sredstvo; sredstvo protiv peruti; sredstvo za klizanje; sredstvo za vlaženje kože.
9. Kompozicija prema patentnom zahtjevu 6, gdje je sredstvo zaštitno sredstvo izabrano iz grupe koju čine: sredstvo koje apsorbira UV zračenje, repelent insekata, antibakterijsko sredstvo, sredstvo protiv gljivica; antivirusno sredstvo, sredstvo protiv nematoda.
10. Kompozicija prema bilo kojem od patentnih zahtjeva od 1 do 9 za kontrolu transepidermalnog gubitka vode.
HRP20220378TT 2009-11-03 2010-11-03 Kompozicija koja oblikuje lipidni sloj za primjenu na površinu živog organizma HRP20220378T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0901409 2009-11-03
EP10828610.5A EP2496263B1 (en) 2009-11-03 2010-11-03 Lipid layer forming composition for administration onto a surface of a living organism
PCT/SE2010/000268 WO2011056115A1 (en) 2009-11-03 2010-11-03 Lipid layer forming composition for administration onto a surface of a living organism

Publications (1)

Publication Number Publication Date
HRP20220378T1 true HRP20220378T1 (hr) 2022-05-13

Family

ID=43970155

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20220378TT HRP20220378T1 (hr) 2009-11-03 2010-11-03 Kompozicija koja oblikuje lipidni sloj za primjenu na površinu živog organizma

Country Status (21)

Country Link
US (2) US9884119B2 (hr)
EP (1) EP2496263B1 (hr)
JP (2) JP5877790B2 (hr)
KR (1) KR101748224B1 (hr)
CN (1) CN102665766B (hr)
AU (1) AU2010316005B2 (hr)
CA (1) CA2779432C (hr)
CY (1) CY1125098T1 (hr)
DK (1) DK2496263T3 (hr)
ES (1) ES2908689T3 (hr)
HK (1) HK1173666A1 (hr)
HR (1) HRP20220378T1 (hr)
HU (1) HUE057866T2 (hr)
IL (1) IL219438A (hr)
NZ (1) NZ599933A (hr)
PL (1) PL2496263T3 (hr)
PT (1) PT2496263T (hr)
RS (1) RS63043B1 (hr)
RU (1) RU2578430C2 (hr)
SI (1) SI2496263T1 (hr)
WO (1) WO2011056115A1 (hr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2496263T3 (da) 2009-11-03 2022-03-28 Lipidor Ab Lipidlagsdannende sammensætning til administration på en overflade af en levende organisme
US20140044779A1 (en) * 2011-04-18 2014-02-13 Lipidor Ab Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent
SE1300709A1 (sv) * 2013-11-14 2015-05-15 Lipidor Ab Komposition och metod för topikal behandling
AU2012251135A1 (en) * 2011-05-02 2013-11-07 Lipidor Ab Treatment of psoriasis
AU2012273210B2 (en) 2011-06-18 2016-01-07 Thompson Cooper Laboratories, Llc Compositions for depositing agents using highly volatile silicone solvents
JP6244101B2 (ja) * 2013-04-24 2017-12-06 ロート製薬株式会社 ミノキシジル含有外用組成物
JP6261874B2 (ja) * 2013-04-24 2018-01-17 ロート製薬株式会社 ミノキシジル含有外用組成物
BR112015027436A8 (pt) * 2013-05-03 2018-01-16 Lipidor Ab composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos
ES2745093T5 (es) * 2013-11-14 2022-11-10 Lipidor Ab Portador tópico pulverizable y composición que comprende fosfatidilcolina
JP2017210480A (ja) * 2017-08-07 2017-11-30 ロート製薬株式会社 ミノキシジル含有外用組成物
JP2017226692A (ja) * 2017-09-05 2017-12-28 ロート製薬株式会社 ミノキシジル含有外用組成物
JP2018199738A (ja) * 2018-10-02 2018-12-20 ロート製薬株式会社 ミノキシジル含有外用組成物
JP2018199739A (ja) * 2018-10-02 2018-12-20 ロート製薬株式会社 ミノキシジル含有外用組成物
JP2020189883A (ja) * 2020-08-24 2020-11-26 ロート製薬株式会社 ミノキシジル含有外用組成物
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
JPS6396114A (ja) 1986-10-09 1988-04-27 Asanuma Sogyo Kk メイクアツプ化粧料
JPS63260955A (ja) * 1987-04-20 1988-10-27 Shin Etsu Chem Co Ltd シリコ−ン組成物
JPS63275518A (ja) 1987-05-08 1988-11-14 Terumo Corp 半固形組成物
US5336692A (en) * 1990-06-28 1994-08-09 Medicis Pharmaceutical Corporation Ointment base and method of use
IT1269634B (it) * 1994-05-06 1997-04-08 Indena Spa Medicamento topico ad attivita' cicatrizzante
US5540934A (en) * 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
GB2302807A (en) 1995-07-04 1997-02-05 Surtech Int Ltd Method and composition for treating atopic eczema
US5911977A (en) 1997-10-06 1999-06-15 Chesebrough-Pond's Usa Co. Alcoholic antiperspirant aerosol spray products
SE9800729L (sv) 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
AU2002317981B2 (en) 2001-07-24 2006-12-07 Advanced Biotechnologies Topical pharmaceutical formulation
JP2003104826A (ja) * 2001-09-28 2003-04-09 Kanebo Ltd Ｗ／ｏ／ｗ型複合エマルジョン
JP2003261435A (ja) 2002-03-11 2003-09-16 Ichimaru Pharcos Co Ltd エネルギー変性剤
US7229654B2 (en) * 2002-11-26 2007-06-12 Kraft Foods Holdings, Inc. Multilayer edible moisture barrier for food products and method of use
FR2856301B1 (fr) 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
GB0426010D0 (en) 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
CA2619886C (en) 2005-08-17 2016-01-19 Ann Beal Salamone Conformable solvent-based bandage and coating material
US20080124296A1 (en) 2006-11-22 2008-05-29 L'oreal S.A. Compositions containing microspheres
JP2009149624A (ja) 2007-11-30 2009-07-09 Mandom Corp 皮膚用化粧料
US20100080768A1 (en) 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
DK2496263T3 (da) 2009-11-03 2022-03-28 Lipidor Ab Lipidlagsdannende sammensætning til administration på en overflade af en levende organisme
BR112015027436A8 (pt) 2013-05-03 2018-01-16 Lipidor Ab composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos

Also Published As

Publication number Publication date
RU2578430C2 (ru) 2016-03-27
US20160271256A1 (en) 2016-09-22
HUE057866T2 (hu) 2022-06-28
RU2012117954A (ru) 2013-12-10
AU2010316005A1 (en) 2012-05-17
CA2779432C (en) 2017-05-23
ES2908689T3 (es) 2022-05-03
CA2779432A1 (en) 2011-05-12
CN102665766B (zh) 2016-01-20
NZ599933A (en) 2014-08-29
DK2496263T3 (da) 2022-03-28
CY1125098T1 (el) 2024-02-16
KR20120117767A (ko) 2012-10-24
IL219438A (en) 2017-04-30
SI2496263T1 (sl) 2022-05-31
PT2496263T (pt) 2022-03-28
US10137198B2 (en) 2018-11-27
EP2496263A4 (en) 2014-04-09
RS63043B1 (sr) 2022-04-29
EP2496263A1 (en) 2012-09-12
JP2016047819A (ja) 2016-04-07
KR101748224B1 (ko) 2017-06-16
EP2496263B1 (en) 2021-12-29
US9884119B2 (en) 2018-02-06
JP5877790B2 (ja) 2016-03-08
IL219438A0 (en) 2012-06-28
WO2011056115A8 (en) 2011-06-30
PL2496263T3 (pl) 2022-04-25
JP6162763B2 (ja) 2017-07-12
AU2010316005B2 (en) 2014-07-24
US20120233728A1 (en) 2012-09-13
CN102665766A (zh) 2012-09-12
WO2011056115A1 (en) 2011-05-12
HK1173666A1 (zh) 2013-05-24
JP2013510084A (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
HRP20220378T1 (hr) Kompozicija koja oblikuje lipidni sloj za primjenu na površinu živog organizma
Sharma et al. Antiemetic efficacy of ginger (Zingiber officinale) against cisplatin-induced emesis in dogs
ATE418324T1 (de) Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen
US20080031979A1 (en) Use of extracts for the treatment of viral disorders
BRPI0408559A (pt) composições farmacêuticas dispersìveis para o tratamento de mastite e distúrbios óticos
KR102587297B1 (ko) 수면장애 예방 또는 치료용 조성물
CN103432584A (zh) 清凉止痒组合物及应用其的纸巾
AR055591A1 (es) Una composicion topica protectora de la piel y su uso
ITMI20061132A1 (it) Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
CN102846504A (zh) 一种艾草驱蚊沐浴露
CN103566057A (zh) 一种消炎镇痛膏
CA2609347C (en) Use of chalcones for the treatment of viral disorders
BR112015027436A8 (pt) composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos
US11318093B2 (en) Dental topical anesthetic gel
CN105943454A (zh) 无刺激型长效驱蚊液
RU2011129815A (ru) Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи
US20160317480A1 (en) Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness
US20190192658A1 (en) Topical pain relief composition
ITUB20159582A1 (it) Composizione, per uso topico, utile per la prevenzione di disturbi di tipo infiammatorio e/o infettivo delle mucose.
WO2019244160A1 (en) Cannabidiol-containing antimicrobial non-irritating hyperosmotic compositions
KR101913564B1 (ko) 무좀치료 연고조성물
WO2022150934A1 (es) Memoria descriptiva
CN104606295A (zh) 非抗生素类抗真菌外用药
CN101874797B (zh) 紫苏烯在制备抗炎药物中的用途
US20140256692A1 (en) Composition and Method for Alleviation of Pain and Inflammation